FDA sharpens import inspection tools

Under its Analytical Tools Initiative, the FDA is training import personnel to use a hand-held device for detecting counterfeit drugs and packaging. The regulator is also training staff on a portable X-ray fluorescence device capable of detecting toxic elements. Report

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.